- OptimizeRx Reports First Quarter 2024 Financial Results
- OptimizeRx to Participate in Upcoming Investor Conferences
- OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
- OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
- OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
- OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
- OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
- OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
- OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
- OptimizeRx to Participate in Upcoming Investor Conferences
More ▼
Key statistics
On Thursday, OPTIMIZERx Corp (OPRX:NAQ) closed at 12.30, -26.10% below its 52-week high of 16.65, set on Mar 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.58 |
---|---|
High | 12.70 |
Low | 12.23 |
Bid | 4.94 |
Offer | 16.25 |
Previous close | 12.57 |
Average volume | 200.55k |
---|---|
Shares outstanding | 18.27m |
Free float | 15.96m |
P/E (TTM) | -- |
Market cap | 229.65m USD |
EPS (TTM) | -1.03 USD |
Data delayed at least 15 minutes, as of May 23 2024 21:00 BST.
More ▼